dihexa potency compared to bdnf synaptogenesis shows neurotrophic activity exceeding in preclinical studies | Alpha BioMed posted on the topic Dihexa (also known as PNB-0408)

Dihexa (also known as PNB 0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the bloodbrain barrier and has shown synaptogenic effects in preclinical models. The often quoted The Role of BDNF in Age Dependent Changes of Excitatory and Inhibitory Synaptic Markers in the Human Prefrontal Cortex Neuropsychopharmacology Dihexa (PNB 0408) Dosing, Side Effects, FDA Status & Research PeptIQ PeptIQ BDNF as a Promising Therapeutic Agent in Parkinson's Disease

SKU: 14849805481 · From cantondelareina.com.ar